Adenoviral vector encoding malaria antigen

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/015 (2006.01) C07K 14/445 (2006.01) C12N 15/861 (2006.01) C12N 15/863 (2006.01)

Patent

CA 2683679

The invention provides recombinant adenoviral vectors which are capable of eliciting immunity against the pre-erythrocytic stage of the life cycle of the malaria parasite. In particular, the invention provides a recombinant, replication deficient simian adenoviral vector which encodes an antigen comprising the thrombospondin-related adhesion protein (TRAP), and also immunogenic compositions (e.g. vaccines) comprising the vector and methods of using such compositions.

L'invention concerne des vecteurs adénoviraux de recombinaison qui sont capables de provoquer une immunité contre le stade pré-érythrocytique du cycle de vie du parasite du paludisme. L'invention concerne notamment un vecteur adénoviral de recombinaison du singe à réplication déficiente qui code un antigène qui comprend la protéine d'adhésion associée à la thrombospondine (TRAP), ainsi que des compositions immunogènes (p. ex. vaccins) qui comprennent le vecteur et des procédés d'utilisation de telles compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenoviral vector encoding malaria antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenoviral vector encoding malaria antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenoviral vector encoding malaria antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1368058

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.